Recent years have witnessed significant developments in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://declanbbvo405710.total-blog.com/glp-1-receptor-agonists-retatrutide-and-trizepatide-advancements-64246064